Callan JMB (NASDAQ:CJMB) Issues Quarterly Earnings Results

Callan JMB (NASDAQ:CJMB) issued its earnings results on Tuesday. The company reported ($0.56) earnings per share for the quarter, FiscalAI reports. Callan JMB had a negative return on equity of 133.43% and a negative net margin of 112.72%.The business had revenue of $1.16 million for the quarter.

Callan JMB Stock Up 7.8%

NASDAQ:CJMB traded up $0.09 during trading hours on Tuesday, hitting $1.25. 122,596 shares of the company’s stock traded hands, compared to its average volume of 280,611. Callan JMB has a 52 week low of $1.08 and a 52 week high of $5.88. The business’s fifty day simple moving average is $1.80 and its two-hundred day simple moving average is $2.67. The firm has a market cap of $5.78 million and a P/E ratio of -1.01.

Insider Buying and Selling at Callan JMB

In related news, insider David J. Croyle acquired 14,805 shares of the company’s stock in a transaction dated Friday, March 6th. The stock was bought at an average cost of $1.76 per share, with a total value of $26,056.80. Following the acquisition, the insider owned 789,805 shares of the company’s stock, valued at approximately $1,390,056.80. The trade was a 1.91% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 73.87% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Callan JMB

A hedge fund recently raised its stake in Callan JMB stock. Creative Planning increased its holdings in Callan JMB Inc. (NASDAQ:CJMB) by 41.7% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 170,008 shares of the company’s stock after purchasing an additional 50,000 shares during the period. Creative Planning owned approximately 3.79% of Callan JMB worth $830,000 as of its most recent SEC filing.

Analyst Ratings Changes

CJMB has been the subject of several analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Callan JMB in a report on Monday, December 22nd. Wall Street Zen upgraded Callan JMB to a “hold” rating in a research report on Saturday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Callan JMB has an average rating of “Sell”.

About Callan JMB

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.